Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

US ramps up swine flu protection

Nature (2009)Cite this article

New technologies may help boost H1N1 vaccine production.

The United States has awarded a US$90-million contract to biotech company MedImmune to produce a new live attenuated virus vaccine against influenza A (H1N1) swine flu. The 1 June announcement follows the placing of almost $1 billion in vaccine-supply contracts to pharmaceutical companies a fortnight ago.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Declan Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Swine flu Special

Related external links

Biomedical Advanced Research and Development Authority (BARDA)

European Medicines Agency

WHO

CDC

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Butler, D. US ramps up swine flu protection. Nature (2009). https://doi.org/10.1038/news.2009.543

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2009.543

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing